We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 9,920 results
  1. Eosinophils promote CD8+ T cell memory generation to potentiate anti-bacterial immunity

    Memory CD8 + T cell generation is crucial for pathogen elimination and effective vaccination against infection. The cellular and molecular circuitry...

    Jun Zhou, Jiaqi Liu, ... Xuetao Cao in Signal Transduction and Targeted Therapy
    Article Open access 28 February 2024
  2. CD8-positive T-cell lymphoproliferative disorder of the uterus: a new subtype of indolent extranodal T-cell neoplasm?

    A 51-year-old female with menorrhagia was found to have a cervical polyp. Polypectomy and endometrial curettage showed an atypical lymphoid...

    Reham Ahmed, Andrew L. Feldman in Journal of Hematopathology
    Article 08 July 2024
  3. GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration

    Purpose

    The variable responses to immunotherapy observed in gastric cancer (GC) patients can be attributed to the intricate nature of the tumor...

    Wen**g Zhao, Ziwei Liang, ... Jiannan Yao in Cancer Immunology, Immunotherapy
    Article Open access 15 May 2024
  4. Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma

    Although chimeric antigen receptor (CAR) T cells have become an important treatment option for patients with relapsed/refractory B-cell malignancies,...

    Yao Wang, Chuan Tong, ... Weidong Han in Signal Transduction and Targeted Therapy
    Article Open access 25 October 2023
  5. Tissue-resident memory CD103+CD8+ T cells in colorectal cancer: its implication as a prognostic and predictive liver metastasis biomarker

    Background

    Tissue-resident memory CD103+CD8+ T cells (CD103+CD8+ TRMs) are important components of anti-tumor immunity. However, the significance of...

    Shi** Liu, Penglin Wang, ... **ghua Pan in Cancer Immunology, Immunotherapy
    Article Open access 02 July 2024
  6. Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection

    The immunoprotective components control COVID-19 disease severity, as well as long-term adaptive immunity maintenance and subsequent reinfection risk...

    Gang Yang, **peng Cao, ... Zhongfang Wang in Signal Transduction and Targeted Therapy
    Article Open access 29 May 2024
  7. IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models

    Clinically approved head and neck squamous cell carcinoma (HNSCC) immunotherapies manipulate the immune checkpoint blockade (ICB) axis but have had...

    Justin Yu, Jacob Gadwa, ... Sana D. Karam in Cancer Immunology, Immunotherapy
    Article Open access 30 March 2024
  8. Targeting a disintegrin and metalloprotease (ADAM) 17-CD122 axis enhances CD8+ T cell effector differentiation and anti-tumor immunity

    CD8 + T cell immune responses are regulated by multi-layer networks, while the post-translational regulation remains largely unknown. Transmembrane...

    Lina Sun, Anjun Jiao, ... Baojun Zhang in Signal Transduction and Targeted Therapy
    Article Open access 26 June 2024
  9. Pan-cancer analysis for the prognostic and immunological role of CD47: interact with TNFRSF9 inducing CD8 + T cell exhaustion

    Purpose

    The research endeavors to explore the implications of CD47 in cancer immunotherapy effectiveness. Specifically, there is a gap in...

    Hongxin Liang, Yong Zheng, ... Haiyu Zhou in Discover Oncology
    Article Open access 08 May 2024
  10. A modified immune cell infiltration score achieves ideal stratification for CD8+ T cell efficacy and immunotherapy benefit in hepatocellular carcinoma

    Immunotherapy, which aims to enhance the function of T cells, has emerged as a novel therapeutic approach for hepatocellular carcinoma (HCC)....

    Banglun Pan, Yue Luo, ... Nanhong Tang in Cancer Immunology, Immunotherapy
    Article 27 September 2023
  11. Evaluation of vital genes correlated with CD8 + T cell infiltration as prognostic biomarkers in stomach adenocarcinoma

    Background

    Infiltration of CD8 + T cells in the tumor microenvironment is correlated with better prognosis in various malignancies. Our study aimed to...

    Dun Pan, Hui Chen, ... Liangqing Li in BMC Gastroenterology
    Article Open access 17 November 2023
  12. Chronic lymphocytic leukemia presence impairs antigen-specific CD8+ T-cell responses through epigenetic reprogramming towards short-lived effectors

    T-cell dysregulation in chronic lymphocytic leukemia (CLL) associates with low response rates to autologous T cell-based therapies. How CLL affects...

    Anne W. J. Martens, Inga Kavazović, ... Arnon P. Kater in Leukemia
    Article 19 January 2023
  13. Identification of co-expressed gene networks promoting CD8+ T cell infiltration and having prognostic value in uveal melanoma

    Current immunotherapies are unsatisfactory against uveal melanoma (UM); however, elevated CD8 + T cell infiltration level indicates poor prognosis in...

    Chun Zhang, **g ** Xu in BMC Ophthalmology
    Article Open access 10 August 2023
  14. Single-cell combined bioinformatics analysis: construction of immune cluster and risk prognostic model in kidney renal clear cells based on CD8+ T cell-associated genes

    Background

    Kidney cancer is an immunogenic solid tumor, characterized by high tumor burden and infiltration of CD8 + T cells. Although immunotherapy...

    Haifeng Gao, Hang Sun, ... **ke Qian in European Journal of Medical Research
    Article Open access 30 January 2024
  15. CD57-positive CD8 + T cells define the response to anti-programmed cell death protein-1 immunotherapy in patients with advanced non-small cell lung cancer

    Immune checkpoint inhibitors have transformed the treatment landscape of non-small cell lung cancer (NSCLC). However, accurately identifying patients...

    Wenjia Sun, Fengqi Qiu, ... Jianya Zhou in npj Precision Oncology
    Article Open access 31 January 2024
  16. Eribulin promotes proliferation of CD8+ T cells and potentiates T cell-mediated anti-tumor activity against triple-negative breast cancer cells

    Purpose

    Chemotherapeutic agents exert immunomodulatory effects on triple-negative breast cancer (TNBC) cells and immune cells. Eribulin favorably...

    Tadafumi Shimizu, Takaaki Oba, ... Ken-ichi Ito in Breast Cancer Research and Treatment
    Article 21 September 2023
  17. Establishment and validation of a novel CD8+ T cell-associated prognostic signature for predicting clinical outcomes and immunotherapy response in hepatocellular carcinoma via integrating single-cell RNA-seq and bulk RNA-seq

    CD8+ T lymphocytes are critical in the immune response against neoplasms, yet the prognostic relevance of CD8+ T cell-associated genes in...

    Caihao Qu, **n Yan, ... Yumin Li in Discover Oncology
    Article Open access 20 June 2024
  18. High TOX expression on CD8+ T cells in pure red cell aplasia

    Thymocyte selection-associated high-mobility group box protein (TOX) is an important molecule regulating the development and exhaustion of T...

    Haiyue Niu, Li Yan, ... Huaquan Wang in Annals of Hematology
    Article 18 March 2023
  19. Dynamics of pulmonary mucosal cytotoxic CD8 T-cells in people living with HIV under suppressive antiretroviral therapy

    Background

    Despite the success of antiretroviral therapy (ART), people living with HIV (PLWH) suffer from a high burden of pulmonary diseases, even...

    Yulia Alexandrova, Alexis Yero, ... Mohammad-Ali Jenabian in Respiratory Research
    Article Open access 12 June 2024
  20. Spatiotemporal commonality of the TCR repertoire in a T-cell memory murine model and in metastatic human colorectal cancer

    Immune checkpoint inhibitors (ICIs) have shown superior clinical responses and significantly prolong overall survival (OS) for many types of cancer....

    Mizuki Haraguchi, Kazuma Kiyotani, ... Ryohei Katayama in Cancer Immunology, Immunotherapy
    Article 04 June 2023
Did you find what you were looking for? Share feedback.